Help Privacy Policy Disclaimer
  Advanced SearchBrowse




Journal Article

The potential of precision psychiatry: What is in reach?


Koutsouleris,  Nikolaos
Max Planck Fellow Group Precision Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available

Kambeitz-Ilankovic, L., Koutsouleris, N., & Upthegrove, R. (2022). The potential of precision psychiatry: What is in reach? SI, 220(4), 175-178. doi:10.1192/bjp.2022.23.

Cite as: https://hdl.handle.net/21.11116/0000-000A-8E49-5
Progress in developing personalised care for mental disorders is supported by numerous proof-of-concept machine learning studies in the area of risk assessment, diagnostics and precision prescribing. Most of these studies primarily use clinical data, but models might benefit from additional neuroimaging, blood and genetic data to improve accuracy. Combined, multimodal models might offer potential for stratification of patients for treatment. Clinical implementation of machine learning is impeded by a lack of wider generalisability, with efforts primarily focused on psychosis and dementia. Studies across all diagnostic groups should work to test the robustness of machine learning models, which is an essential first step to clinical implementation, and then move to prospective clinical validation. Models need to exceed clinicians' heuristics to be useful, and safe, in routine decision-making. Engagement of clinicians, researchers and patients in digitalisation and 'big data' approaches are vital to allow the generation and accessibility of large, longitudinal, prospective data needed for precision psychiatry to be applied into real-world psychiatric care.